This can lead to activation in COPD of the mammalian target of rapamycin (mTOR) aging pathway via phosphoinositide 3‐kinase (P13K) activation by ROS, resulting in reduced antioxidant defense by FOXO3A inhibition and a loss of autophagy.9 The gene discussed is MTOR; the disease is chronic obstructive pulmonary disease.